Biorbyt

 

Biorbyt is a UK-based supplier specializing in life science reagents. They offer a wide range of products, including antibodies, ELISA kits, small molecules, and proteins. Researchers can choose from thousands of research antibodies and reagents for various applications. Biorbyt collaborates with top scientists and scholars to develop high-quality products, covering areas such as immunology, cell biology, molecular biology, and proteinomics. Their comprehensive offerings include immune assays, protein mass spectrometry, cell culture, custom antibody services, animal model establishment, and biochemical reagents. 

Biorbyt provides valuable reagents and services for biological research. With a wide selection of antibodies, assay kits, small molecules, and proteins, Biorbyt supports scientists in their experiments. They have established stable partnerships with renowned universities, research institutes, pharmaceutical companies, biotech firms, and hospitals worldwide. Biorbyt’s commitment to high-quality products and professional technical services spans immunology, cell biology, molecular biology, proteinomics, and more.

 

Learn more :

 

 

 

 

         

Antibodies - Chicken Ig Why ?

 

 

   

Cancer Pathways

Apoptosis Signaling

 

 

Fix & Perm Cell Fixation

and Permeabilization

 

 

   

         

Immunology Pathways

 

 

Products for advancing

discoveries

 

Working in larger model

animal species

 
 

Watch the videos: 

     

 

       
         

Recombinant Antibodies

 

 

 

 

Cancer Biomarkers

 

 
 
 
SARS-CoV-2 - Baricitinib - Therapeutic Candidates

SARS-CoV-2 - Baricitinib - Therapeutic Candidates


Like ruxolitinib, baricitinib (OLUMIANT) is an inhibitor of Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2) which are tyrosine kinases involved in JAK signaling pathways. Baricitinib is a reversible and selective inhibitor and is indicated in the treatment of moderate to severe active rheumatoid arthritis for its anti-inflammatory effect. It is a second-line therapy, i.e., used after failure of conventional disease-modifying therapies. It can be used alone or in combination with methotrexate (MTX).
A clinical study on the efficacy and safety of baricitinib for the treatment of Covid-19 has begun. The anti-inflammatory activity of this drug may have a potential beneficial effect in the treatment of Covid-19. The use of baritinicib therapy may limit the cytokine release syndrome associated with Covid-19 and may be useful because it acts against a wide range of cytokines.

Search result : 53 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 2
  • Biochemicals 51
  • Inhibitor/Antagonist/Agonist 2
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
orb1226853-25mg
 25mg 
orb1305415-50mg
 50mg 
orb1901579-50mg
 50mg 
orb1226853-10mg
 10mg 
orb669003-5mg
 5mg 
orb1305415-100mg
 100mg 
orb1901580-5mg
 5mg 
orb1305415-2mg
 2mg 
orb1090030-25mg
 25mg 
orb1227510-250mg
 250mg 
orb1090030-50mg
 50mg 
orb1226853-100mg
 100mg 
orb1305415-5mg
 5mg 
orb1226853-5mg
 5mg 
orb1090030-5mg
 5mg 
orb1226853-50mg
 50mg 
orb1901583-10mg
 10mg 
orb1305415-1mg
 1mg 
orb1226853-2mg
 2mg 
orb1226853-200mg
 200mg